TMC Life Sciences Berhad (KLSE:TMCLIFE)

Malaysia flag Malaysia · Delayed Price · Currency is MYR
0.450
+0.015 (3.45%)
At close: Dec 4, 2025
-11.76%
Market Cap 783.85M
Revenue (ttm) 364.14M
Net Income (ttm) 5.08M
Shares Out 1.74B
EPS (ttm) 0.00
PE Ratio 154.22
Forward PE n/a
Dividend 0.00 (0.41%)
Ex-Dividend Date Dec 8, 2025
Volume 691,900
Average Volume 138,560
Open 0.425
Previous Close 0.435
Day's Range 0.425 - 0.450
52-Week Range 0.365 - 0.530
Beta 0.29
RSI 61.34
Earnings Date Nov 17, 2025

About TMC Life Sciences Berhad

TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; property investment; providing pharmacy services and products; management support services; development, marketing, and management of healthcare programmes; a... [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Founded 1994
Country Malaysia
Stock Exchange Bursa Malaysia
Ticker Symbol TMCLIFE
Full Company Profile

Financial Performance

In 2025, TMC Life Sciences Berhad's revenue was 345.63 million, a decrease of -0.23% compared to the previous year's 346.42 million. Earnings were 3.61 million, a decrease of -91.13%.

Financial Statements

News

There is no news available yet.